NIAMS Policy for Submission of Applications Containing Clinical Trials

FYI:

  • Notice of NIAMS Policy for Submission of Applications Containing Clinical Trials
    (NOT-AR-13-015)
    National Institute of Arthritis and Musculoskeletal and Skin Diseases

Effectively immediately, NIAMS will not accept investigator-initiated R01 applications and subsequent revisions containing clinical trials.

 

Please note that NIH’s definition of a clinical trial is broader than most:

 

“A clinical trial is a prospective biomedical or behavioral research study of human subjects designed to answer specific questions about the safety, tolerability, efficacy and/or effectiveness of pharmacologic, behavioral, biologic, surgical, or device (invasive or non-invasive) interventions.”

 

Questions about this or other notices sent from the SPA listserv may be directed to your Sponsored Projects Contract & Grant Officer.

Scroll to Top